Cargando…
Randomized clinical trials of COVID-19 vaccines: Do adenovirus-vector vaccines have beneficial non-specific effects?
We examined the possible non-specific effects of novel mRNA- and adenovirus-vector COVID-19 vaccines by reviewing the randomized control trials (RCTs) of mRNA and adenovirus-vector COVID-19 vaccines. We calculated mortality risk ratios (RRs) for mRNA COVID-19 vaccines vs. placebo recipients and comp...
Autores principales: | Benn, Christine S., Schaltz-Buchholzer, Frederik, Nielsen, Sebastian, Netea, Mihai G., Aaby, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10125209/ https://www.ncbi.nlm.nih.gov/pubmed/37163200 http://dx.doi.org/10.1016/j.isci.2023.106733 |
Ejemplares similares
-
Beneficial non-specific effects of live vaccines against COVID-19 and other unrelated infections
por: Aaby, Peter, et al.
Publicado: (2023) -
Reactivation of BCG vaccination scars after vaccination with mRNA-Covid-vaccines: two case reports
por: Mohamed, Libin, et al.
Publicado: (2021) -
The real-life number of neonatal doses of Bacille Calmette-Guérin vaccine in a 20-dose vial
por: Schaltz-Buchholzer, Frederik, et al.
Publicado: (2017) -
Implications of Non-Specific Effects for Testing, Approving, and Regulating Vaccines
por: Benn, Christine Stabell, et al.
Publicado: (2023) -
A Randomized Trial of a Standard Dose of Edmonston-Zagreb Measles Vaccine Given at 4.5 Months of Age: Effect on Total Hospital Admissions
por: Martins, Cesario L., et al.
Publicado: (2014)